Inventor · disambiguated record
Cheng Luo
Also filed as: LUO CHENG
7 granted patents·11 pending applications·5 citations·filing 2006–2023
72Inventor score
Files withSHANGHAI INST MATERIA MEDICA CAS5WIGEN BIOMEDICINE TECH SHANGHAI CO LTD4NANJING SANHOME PHARMACEUTICAL CO LTD3SHANGHAI INST MATERIA MEDICA2UNIV SOUTHWEST PETROLEUM2
Top patents by PatentIndex Score
18 records- 0178US11021457B2Class of isoindolone-imide ring-1,3-dione-2-ene compounds, composition and use thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2018·Granted Jun 1, 2021·2 cites·9 claims
- 0277US11529321B2Use of aminomethylenecyclohexane-1,3-dione compoundWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2018·Granted Dec 20, 2022·1 cites·2 claims
- 0371US11319303B2Compound used as autophagy regulator, and preparation method therefor and uses thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2018·Granted May 3, 2022·1 cites·6 claims
- 0466US11013745B2Triazolopyrimidine, triazolopyridine compounds, and the composition thereof for treating PRC2-mediated diseasesSHANGHAI INST MATERIA MEDICA CAS·Filed 2018·Granted May 25, 2021·1 cites·18 claims
- 0562US2025125004A1Systems and methods for post-translational modification-inspired drug design and screeningENSEM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0656US2024262915A1Anti-tigit antibody and double antibody and their applicationNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0753US2024033244A1Compositions and methods for inhibiting ythdf1SHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Application pending·0 cites
- 0851US2022332829A1Anti-b7-h3 antibody and application thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0949US2023090014A1Anti-cd47/anti-pd-l1 antibody and applications thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1049US2025289812A1Compound for treating thrombotic diseasesSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Application pending·0 cites
- 1149US2023334199A1Calculation methods for predicting proppant embedding depth based on shale softening effectUNIV SOUTHWEST PETROLEUM·Filed 2023·Application pending·0 cites
- 1248US2024133281A1Calculation systems for predicting proppant embedding depth based on shale softening effectUNIV SOUTHWEST PETROLEUM·Filed 2023·Application pending·0 cites
- 1344US2016074373A1Methods and compositions for inhibiting human copper trafficking proteins atox1 and ccsSHANGHAI INST MATERIA MEDICA·Filed 2014·Application pending·0 cites
- 1443US12172989B2Histone acetyltransferase (HAT) inhibitor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Dec 24, 2024·0 cites·17 claims
- 1542US2009182133A1Benzopyranone derivatives and their use as anti-viral agentsSHANGHAI INST MATERIA MEDICA·Filed 2006·Application pending·0 cites
- 1640US2020069609A1Method for covalent bond modifying mammalian atg8 homologueWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2018·Application pending·0 cites
- 1739US11427593B2Bromodomain inhibitor compound and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2019·Granted Aug 30, 2022·0 cites·13 claims
- 1829US8501741B2Optically active compound of prulifloxacin for treating infection and preparation method thereofYING JUN·Filed 2010·Granted Aug 6, 2013·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Cheng Luo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →